NEW YORK (GenomeWeb News) – A team of American and German researchers has used a systems biology approach to integrate various genomic and clinical features of brain cancer. In the process, the team found a set of non-random mutations that often co-exist in cancer — and pulled out a handful of genes in the brain cancer network that were linked to patient survival.

The group's research appears in a pair of papers in today's issue of the Journal of the American Medical Association.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.